In modern functional genomics, understanding how specific genes control cellular behavior requires both targeted intervention and high-resolution analysis. That’s where Perturb-Seq comes in—a method ...
Ever since artificial intelligence (AI) drug developer Xaira Therapeutics launched in April 2024 with a jaw-dropping $1 billion in committed capital and a star-studded leadership lineup—including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback